Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC vs LR-PRP vs HA for Knee Osteoarthritis
NCT03825133Phase 4Completed
- Sponsor
- Clinical Center of Vojvodina
- Start
- Apr 2016
- Primary completion
- Nov 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised trial of autologous bone marrow cell concentrate and Leukocyte-Rich Platelet-Rich Plasma in knee osteoarthritis (OA) (3 arms), sponsored by Clinical Center of Vojvodina. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index at 12 months and Knee Injury and Osteoarthritis Outcome Score at 12 months. Started Apr 2016; status: completed.
02
Drugs
autologous bone marrow cell concentrateLeukocyte-Rich Platelet-Rich Plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03825133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03825133.